A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus
Clinical trial NCT07630714 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07630714
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-28
- Primary completion
- 2030-09-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.